[89Zr]Zr-DFO-Trodelvy

N/A

Report date: 2026/04/16 20:00:17

Base Information

Drug Name[89Zr]Zr-DFO-Trodelvy
Drug Alias NameN/A
ClassificationRadiation-emitting products > Nuclides > Zirconium > 89ZrRadiation-emitting products > Radioactive diagnostic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4] 
Mechanisms of ActionTumor-associated calcium signal transducer 2 binders
TargetsTumor-associated calcium signal transducer 2
Therapy Area/IndicationsUrinary Bladder Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesThe First Affiliated Hospital Of Beijing UniversityUniversity Of Wisconsin-MadisonThe First Affiliated Hospital Of Zhengzhou University
China Registration ClassN/A

Develop Information

Active CompaniesThe First Affiliated Hospital Of Beijing UniversityThe First Affiliated Hospital Of Zhengzhou UniversityUniversity Of Wisconsin-Madison
Inactive CompaniesN/A
Active IndicationsUrinary Bladder Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A